Alfuzosin
The risk or severity of hypotension can be increased when Alfuzosin is combined with Cyclandelate.
Amobarbital
The metabolism of Cyclandelate can be increased when combined with Amobarbital.
Amorolfine
The therapeutic efficacy of Amorolfine can be increased when used in combination with Cyclandelate.
Advertisement
Amphotericin B
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Cyclandelate.
amphotericin B liposomal
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Cyclandelate.
Anidulafungin
The therapeutic efficacy of Anidulafungin can be increased when used in combination with Cyclandelate.
Advertisement
Artemether
The therapeutic efficacy of Artemether can be increased when used in combination with Cyclandelate.
Barbexaclone
The metabolism of Cyclandelate can be increased when combined with Barbexaclone.
Barbital
The metabolism of Cyclandelate can be increased when combined with Barbital.
Advertisement
Benzoic Acid
The therapeutic efficacy of Benzoic Acid can be increased when used in combination with Cyclandelate.
Bifonazole
The therapeutic efficacy of Bifonazole can be increased when used in combination with Cyclandelate.
Bunazosin
The risk or severity of hypotension can be increased when Bunazosin is combined with Cyclandelate.
Butenafine
The therapeutic efficacy of Butenafine can be increased when used in combination with Cyclandelate.
Butoconazole
The therapeutic efficacy of Butoconazole can be increased when used in combination with Cyclandelate.
Calcium Acetate
The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Calcium Acetate.
Calcium Chloride
The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Calcium Chloride.
Calcium Chloride Anhydrous
The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Calcium Chloride.
Calcium Citrate
The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Calcium Citrate.
Calcium Glubionate
The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Calcium glubionate.
Calcium gluceptate
The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Calcium Gluceptate.
Calcium Gluconate
The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Calcium gluconate.
Calcium Lactate
The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Calcium lactate.
Carvedilol
The risk or severity of hypotension can be increased when Carvedilol is combined with Cyclandelate.
Casein Allergenic Extract
The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Casein.
Caspofungin
The therapeutic efficacy of Caspofungin can be increased when used in combination with Cyclandelate.
Chloroxine
The therapeutic efficacy of Chloroxine can be increased when used in combination with Cyclandelate.
Ciclopirox
The therapeutic efficacy of Ciclopirox can be increased when used in combination with Cyclandelate.
Cimetidine
The serum concentration of Cyclandelate can be increased when it is combined with Cimetidine.
Clopidogrel
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Cyclandelate.
Clotrimazole
The therapeutic efficacy of Clotrimazole can be increased when used in combination with Cyclandelate.
Cordycepin
The therapeutic efficacy of Cordycepin can be increased when used in combination with Cyclandelate.
Cyclosporine
The therapeutic efficacy of Cyclosporine can be increased when used in combination with Cyclandelate.
Decanoic Acid
The therapeutic efficacy of Capric acid can be increased when used in combination with Cyclandelate.
Doxazosin
The risk or severity of hypotension can be increased when Doxazosin is combined with Cyclandelate.
Econazole
The therapeutic efficacy of Econazole can be increased when used in combination with Cyclandelate.
Econazole Nitrate
The therapeutic efficacy of Econazole can be increased when used in combination with Cyclandelate.
Efavirenz
The serum concentration of Cyclandelate can be decreased when it is combined with Efavirenz.
Efinaconazole
The therapeutic efficacy of Efinaconazole can be increased when used in combination with Cyclandelate.
Fluconazole
The therapeutic efficacy of Fluconazole can be increased when used in combination with Cyclandelate.
Flucytosine
The therapeutic efficacy of Flucytosine can be increased when used in combination with Cyclandelate.
Glyphosate
The therapeutic efficacy of Glyphosate can be increased when used in combination with Cyclandelate.
Griseofulvin
The therapeutic efficacy of Griseofulvin can be increased when used in combination with Cyclandelate.
Griseofulvin microsize
The therapeutic efficacy of Griseofulvin can be increased when used in combination with Cyclandelate.
Haloprogin
The therapeutic efficacy of Haloprogin can be increased when used in combination with Cyclandelate.
Hexetidine
The therapeutic efficacy of Hexetidine can be increased when used in combination with Cyclandelate.
Hexobarbital
The metabolism of Cyclandelate can be increased when combined with Hexobarbital.
Indoramin
The risk or severity of hypotension can be increased when Indoramin is combined with Cyclandelate.
Isoconazole
The therapeutic efficacy of Isoconazole can be increased when used in combination with Cyclandelate.
Itraconazole
The therapeutic efficacy of Itraconazole can be increased when used in combination with Cyclandelate.
Ketoconazole
The therapeutic efficacy of Ketoconazole can be increased when used in combination with Cyclandelate.
Labetalol
The risk or severity of hypotension can be increased when Labetalol is combined with Cyclandelate.
Magnesium Hydroxide
The risk or severity of hypotension and neuromuscular blockade can be increased when Cyclandelate is combined with Magnesium hydroxide.
Magnesium Oxide
The risk or severity of hypotension and neuromuscular blockade can be increased when Cyclandelate is combined with Magnesium oxide.
Magnesium Salicylate
The risk or severity of hypotension and neuromuscular blockade can be increased when Cyclandelate is combined with Magnesium salicylate.
Magnesium Sulfate
The risk or severity of hypotension and neuromuscular blockade can be increased when Cyclandelate is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The risk or severity of hypotension and neuromuscular blockade can be increased when Cyclandelate is combined with Magnesium sulfate.
Mephobarbital
The metabolism of Cyclandelate can be increased when combined with Methylphenobarbital.
Methohexital
The metabolism of Cyclandelate can be increased when combined with Methohexital.
Micafungin
The therapeutic efficacy of Micafungin can be increased when used in combination with Cyclandelate.
Miconazole
The therapeutic efficacy of Miconazole can be increased when used in combination with Cyclandelate.
Miltefosine
The therapeutic efficacy of Miltefosine can be increased when used in combination with Cyclandelate.
Nafcillin
The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Nafcillin.
Naftifine
The therapeutic efficacy of Naftifine can be increased when used in combination with Cyclandelate.
Natamycin
The therapeutic efficacy of Natamycin can be increased when used in combination with Cyclandelate.
Nitroprusside
Cyclandelate may increase the hypotensive activities of Nitroprusside.
Nitroxoline
The therapeutic efficacy of Nitroxoline can be increased when used in combination with Cyclandelate.
Nystatin
The therapeutic efficacy of Nystatin can be increased when used in combination with Cyclandelate.
Oxiconazole
The therapeutic efficacy of Oxiconazole can be increased when used in combination with Cyclandelate.
Pafuramidine
The therapeutic efficacy of Pafuramidine can be increased when used in combination with Cyclandelate.
Pentamidine
The therapeutic efficacy of Pentamidine can be increased when used in combination with Cyclandelate.
Pentobarbital
The metabolism of Cyclandelate can be increased when combined with Pentobarbital.
Phenobarbital
The metabolism of Cyclandelate can be increased when combined with Phenobarbital.
Posaconazole
The therapeutic efficacy of Posaconazole can be increased when used in combination with Cyclandelate.
Prazosin
The risk or severity of hypotension can be increased when Prazosin is combined with Cyclandelate.
Primidone
The metabolism of Cyclandelate can be increased when combined with Primidone.
Rifabutin
The risk or severity of hypotension can be increased when Rifabutin is combined with Cyclandelate.
Rifampin
The risk or severity of hypotension can be increased when Rifampicin is combined with Cyclandelate.
Rifapentine
The risk or severity of hypotension can be increased when Rifapentine is combined with Cyclandelate.
Rifaximin
The risk or severity of hypotension can be increased when Rifaximin is combined with Cyclandelate.
Salicylic Acid
The therapeutic efficacy of Salicylic acid can be increased when used in combination with Cyclandelate.
Secobarbital
The metabolism of Cyclandelate can be increased when combined with Secobarbital.
Sertaconazole
The therapeutic efficacy of Sertaconazole can be increased when used in combination with Cyclandelate.
Silodosin
The risk or severity of hypotension can be increased when Silodosin is combined with Cyclandelate.
Sirolimus
The therapeutic efficacy of Sirolimus can be increased when used in combination with Cyclandelate.
Sulconazole
The therapeutic efficacy of Sulconazole can be increased when used in combination with Cyclandelate.
Tamsulosin
The risk or severity of hypotension can be increased when Tamsulosin is combined with Cyclandelate.
Tavaborole
The therapeutic efficacy of Tavaborole can be increased when used in combination with Cyclandelate.
Terazosin
The risk or severity of hypotension can be increased when Terazosin is combined with Cyclandelate.
Terbinafine
The therapeutic efficacy of Terbinafine can be increased when used in combination with Cyclandelate.
Terconazole
The therapeutic efficacy of Terconazole can be increased when used in combination with Cyclandelate.
Thiamylal
The metabolism of Cyclandelate can be increased when combined with Thiamylal.
Thiopental
The metabolism of Cyclandelate can be increased when combined with Thiopental.
Thiopental Sodium
The metabolism of Cyclandelate can be increased when combined with Thiopental.
Thymol
The therapeutic efficacy of Thymol can be increased when used in combination with Cyclandelate.
Tioconazole
The therapeutic efficacy of Tioconazole can be increased when used in combination with Cyclandelate.
Tolnaftate
The therapeutic efficacy of Tolnaftate can be increased when used in combination with Cyclandelate.
Tricalcium Phosphate
The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Calcium Phosphate.
Trimetrexate
The therapeutic efficacy of Trimetrexate can be increased when used in combination with Cyclandelate.
Urapidil
The risk or severity of hypotension can be increased when Urapidil is combined with Cyclandelate.
Voriconazole
The therapeutic efficacy of Voriconazole can be increased when used in combination with Cyclandelate.
